Neutropenia Due to Cancer Chemotherapy
📧 Sign up to get email alerts when something new happens for Neutropenia Due to Cancer Chemotherapy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-05-03FDA Approved: NIVESTYM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved NIVESTYM (filgrastim-aafi) in a supplemental application submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2015-03-06FDA Approved: ZARXIO — Original Application (Sandoz Inc.)
FDA approved Zarxio (filgrastim-sndz) from Sandoz as a biosimilar to filgrastim. It is indicated to reduce the duration of neutropenia in pa…